JP2025512366A5 - - Google Patents
Info
- Publication number
- JP2025512366A5 JP2025512366A5 JP2024560262A JP2024560262A JP2025512366A5 JP 2025512366 A5 JP2025512366 A5 JP 2025512366A5 JP 2024560262 A JP2024560262 A JP 2024560262A JP 2024560262 A JP2024560262 A JP 2024560262A JP 2025512366 A5 JP2025512366 A5 JP 2025512366A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- pharmaceutical composition
- composition according
- glycine
- proline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263330553P | 2022-04-13 | 2022-04-13 | |
| US63/330,553 | 2022-04-13 | ||
| PCT/US2023/018289 WO2023200842A1 (en) | 2022-04-13 | 2023-04-12 | Compositions and methods for treating solid cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025512366A JP2025512366A (ja) | 2025-04-17 |
| JP2025512366A5 true JP2025512366A5 (https=) | 2026-03-30 |
Family
ID=88330172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024560262A Pending JP2025512366A (ja) | 2022-04-13 | 2023-04-12 | 固形がんを処置するための組成物および方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250332226A1 (https=) |
| EP (1) | EP4507793A1 (https=) |
| JP (1) | JP2025512366A (https=) |
| KR (1) | KR20250004257A (https=) |
| CN (1) | CN119677528A (https=) |
| AU (1) | AU2023252830A1 (https=) |
| CA (1) | CA3246603A1 (https=) |
| IL (1) | IL316053A (https=) |
| MX (1) | MX2024012316A (https=) |
| WO (1) | WO2023200842A1 (https=) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4486408A (en) * | 1981-04-07 | 1984-12-04 | Kiel Johnathan L | Insoluble crosslinked cytotoxic oxidase-peroxidase system |
| WO1990003185A1 (en) * | 1988-09-28 | 1990-04-05 | Ideon Corporation | Combination enzyme immunotherapeutics |
| WO2007103525A2 (en) * | 2006-03-09 | 2007-09-13 | Glanbia Nutritionals (Ireland) Limited | Cationic whey protein composition |
| WO2013009910A2 (en) * | 2011-07-11 | 2013-01-17 | Exoxemis, Inc. | Eosinophil peroxidase compositions and methods of their use |
| WO2021202592A2 (en) * | 2020-03-30 | 2021-10-07 | Oregon Health & Science University | Monoclonal antibodies for intracellular delivery of payloads |
| CA3196357A1 (en) * | 2020-11-11 | 2022-05-19 | Robert C. Allen | Compositions and methods for treating solid cancer |
-
2023
- 2023-04-12 US US18/855,270 patent/US20250332226A1/en active Pending
- 2023-04-12 CN CN202380033790.0A patent/CN119677528A/zh active Pending
- 2023-04-12 AU AU2023252830A patent/AU2023252830A1/en active Pending
- 2023-04-12 WO PCT/US2023/018289 patent/WO2023200842A1/en not_active Ceased
- 2023-04-12 EP EP23788886.2A patent/EP4507793A1/en active Pending
- 2023-04-12 JP JP2024560262A patent/JP2025512366A/ja active Pending
- 2023-04-12 KR KR1020247037139A patent/KR20250004257A/ko active Pending
- 2023-04-12 IL IL316053A patent/IL316053A/en unknown
- 2023-04-12 CA CA3246603A patent/CA3246603A1/en active Pending
-
2024
- 2024-10-04 MX MX2024012316A patent/MX2024012316A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2177195A1 (en) | Method and composition for treating renal failure | |
| RU2010150428A (ru) | Композиции для усиления антибактериальной активности миелопероксидазы и способы их применения | |
| CA1050890A (en) | Amino acid formulations for patients with liver disease and method of using same | |
| US20200138985A1 (en) | Kit for labeling a prostate-specific membrane antigen ligand with a radioactive isotope | |
| EP0347890B1 (en) | Amino acid nutrient compositions | |
| JP2023512501A5 (https=) | ||
| FR2435247A1 (fr) | Solution d'amino-acides pour la nutrition par voie intraveineuse | |
| Sakai et al. | Leucine‐nitrogen metabolism in the brain of conscious rats: its role as a nitrogen carrier in glutamate synthesis in glial and neuronal metabolic compartments | |
| JP2025512366A5 (https=) | ||
| EA026443B1 (ru) | Меченныелютецием аналоги бомбезина для лучевой терапии | |
| JP2896192B2 (ja) | プライマー組成物 | |
| JP2020111620A5 (https=) | ||
| NZ240057A (en) | Tetrapyrrole derivatives | |
| JP2023548406A5 (https=) | ||
| CA2379696C (en) | Inhibition of renal uptake of radiomolecules with a combination of lysine and arginine | |
| ATE541568T1 (de) | Infusionsflüssigkeit zur behandlung der anämie bei dialysepatienten | |
| RU2017106945A (ru) | Пептиды, применимые для лечения злокачественной опухоли | |
| JP2019515881A5 (https=) | ||
| JP2025504247A5 (https=) | ||
| CN1071914A (zh) | 血卟啉和其衍生物的复合盐，它们的合成及用做治疗剂 | |
| FR2317917A1 (fr) | Melanges de l-aminoacides et leur utilisation therapeutique | |
| US11980651B1 (en) | Systems and methods for treatment of hearing using dihexa | |
| AU685585B2 (en) | Analgesic activity enhancer | |
| JP2026510850A (ja) | リンカー及びそれを使用したカップリング薬物、抗体薬物複合体並びにその応用 | |
| WO2011153817A1 (zh) | 用作黑皮素4受体激动剂的环肽 |